Industry News
Prostate cancer outcomes predicted by bone turnover markers: findings could influence treatment and clinical trial design
Mar 11, 2014
Biomarkers for bone formation and resorption predict outcomes for men with castration-resistant prostate cancer, a team of researchers from UC Davis and their collaborators have found. Their study, published online in the Journal of the National Cancer Institute, also found that the markers identified a small group of patients who responded to the investigational drug atrasentan. Read More
Being overweight or obese 'a risk factor' for ovarian cancer
Mar 11, 2014
Body weight is not a factor that has been widely associated with the the risk of developing ovarian cancer. But new research suggests that women who are overweight or obese are more likely to develop the disease, compared with women of a healthy weight. Read More
New hope in the battle against glioblastoma offered by anti-psychotic medications
Mar 11, 2014
Researchers at the University of California, San Diego School of Medicine have discovered that FDA-approved anti-psychotic drugs possess tumor-killing activity against the most aggressive form of primary brain cancer, glioblastoma. The finding was published in the online edition of Oncotarget.The team of scientists, led by principal investigator, Clark C. Read More
A step closer to understanding how BPA may promote breast cancer growth
Mar 11, 2014
Subhrangsu Mandal, associate professor of chemistry/biochemistry, and Arunoday Bhan, a PhD student in Mandal's lab, looked at a molecule called RNA HOTAIR. HOTAIR is an abbreviation for long, non-coding RNA, a part of DNA in humans and other vertebrates. Read More
Leukemia gene mutation linked to new childhood growth disorder
Mar 10, 2014
New research led by the Institute of Cancer Research in the UK has discovered that a gene mutation associated with leukemia may be the cause of a newly described condition that affects the growth and intellectual development of children.This is according to a study recently published in the journal Nature Genetics. Read More
Protein synthesis studied in stem cells for the first time
Mar 10, 2014
A new breakthrough in stem cell research has occurred, thanks to scientists at the Children's Medical Center Research Institute at UT Southwestern Medical Center in Dallas, Texas. The researchers claim that protein synthesis - an essential biological process - can be studied in adult stem cells. This is something that scientists have been previously unable to accomplish. Read More
Only 25% of ovarian cancer cases diagnosed in Stage I
Mar 10, 2014
During ovarian cancer awareness month, analysis from global independent analyst firm, Datamonitor Healthcare, has revealed that just 25% of ovarian cancer cases are diagnosed in Stage I despite it being the fourth most common cancer among women. Read More
UV light accelerates melanoma cancer cells that creep along the outside of blood vessels
Mar 10, 2014
Based on the pioneering work of Dr. Claire Lugassy and Dr. Raymond Barnhill at UCLA's Jonsson Comprehensive Cancer Center, a new study provides additional support for a process by which melanoma cells, a deadly form of skin cancer, can spread throughout the body by creeping like tiny spiders along the outside of blood vessels without ever entering the blood stream, and that this process is... Read More
Mutations in leukaemia gene linked to new childhood growth disorder
Mar 10, 2014
Mutations in a gene associated with leukaemia cause a newly described condition that affects growth and intellectual development in children, new research reports.A study led by scientists at The Institute of Cancer Research, London, identified mutations in the DNA methyltransferase gene, DNMT3A, in 13 children. Read More
Targeted therapy with erlotinib may prolong survival of patients with cervical cancer
Mar 10, 2014
A new clinical study has found that erlotinib, a targeted antitumor agent, has promising potential to improve treatment for cervical cancer. Published early online in Cancer, a peer-reviewed journal of the American Cancer Society, the results indicate that larger trials are warranted to determine whether the drug should become part of standard therapy for women with the disease. Read More
Previous Page Next Page